Abstract
With exposure to specific antigenic or mitogenic stimuli, B cells proliferate and subsequently differentiate into antibody-secreting cells. The initial events which accompany activation include an increase in cell size, augmented DNA and RNA synthesis, and changes in cell surface structures. The expression of surface immunoglobulin (SIg) and la, the classical surface markers of B cells, has been extensively studied during in vitro stimulation. Upon activation, resting B cells which express IgM and/or IgD will lose SIgD, and then no longer express membrane Ig or switch to the expression of other isotypes (1). Similarly, resting B cells continue to express la after activation until the plasma cell stage (2). In our laboratory, utilizing a panel of monoclonal antibodies directed against B cell differentiation antigens, we have noted changes in the cell surface pheno- type of resting B cells with activation. Two B cell-restricted antigens, B1 and B4, have been observed to be expressed on resting and activated B cells, and lost prior to the terminal stages of differentiation (3,4). The B2 antigen, present on resting cells is lost during the early stages of activation (4,5). We and others have described additional antigens which are not expressed on resting B cells but only appear with activation. These acti-vation antigens include B-LAST 1 (6), B5 (7), interleukin-2 receptor (IL- 2R) (8,9), BB1 (10), 4F2 (11), and the transferrin receptor (11).
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Goding, J.W., D.W. Scott, and J.E. Layton. 1977. Genetics, cellular expression and function of IgD and IgM receptors. Immunol. Rev. 37: 152.
Halper, J.S., S.M. Fu, C.Y. Winchester, and H.G. Kunkel. 1978. Patterns of expression of human la-like antigens during the terminal stage of B cell development. J. Immunol. 120: 1480.
Nadler, L.M., K.C. Anderson, G. Marti, M. Bates, E. Park, J.F. Daley, and S.F. Schlossman. 1983. B4, a human B lymphocyte-associated antigen ex-pressed on normal, mitogen-activated, and malignant B lymphocytes. J. Immunol. 131: 244.
Boyd, A.W., K.C. Anderson, A.S. Freedman, D.C. Fisher, B. Slaughenhoupt, S.F. Schlossman, and L.M. Nadler, 1985. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody J. Immunol. 134: 1516.
Stashenko, P., L.M. Nadler, R. Hardy, and S.F. Schlossman. 1981. Expression of cell surface markers after human B cell activation. Proc. Natl. Acad. Sci. U.S.A. 78: 3848.
Thorley-Lawson, D.A., R.T. Schooley, A.K. Bhan, and L.M. Nadler. 1982. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell 30: 415.
Freedman, A.S., A.W. Boyd, K.C. Anderson, D.C. Fisher, S.F. Schlossman, and L.M. Nadler. 1985. B5, a new B cell restricted activation antigen. J. Immunol. 134: 2228.
Tsudo, M., T. Uchiyama, and H. Uchino. 1984. Expression of TAC antigen on activated normal human B cells. J. Exp. Med. 160: 612.
Boyd, A.W., D.C. Fisher, D. Fox, S.F. Schlossman, and L.M. Nadler. 1985. Structural and functional characterization of IL-2 receptors on activated B cells. J. Immunol. 134: 2387.
Yokochi, T., R.D. Holly, and E.A. Clark. 1982. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt’s lymphomas. J. Immunol. 128: 823.
Kerhl, J.H., A. Muraguchi, and A.S. Fauci. 1984. Differential expression of cell activation markers after stimulation of resting B lymphocytes. J. Immunol. 132: 2857.
Reinherz, E.L., and S.F. Schlossman. 1980. The differentiation and functions of human T lymphocytes: a review. Cell 19: 821.
Stashenko, P., L.M. Nadler, R. Hardy, and S.F. Schlossman. 1980. Characterization of a human B lymphocyte-specific antigen. J. Immunol. 125: 1678.
Todd, R.F. III, L.M. Nadler, and S.F. Schlossman. 1981. Antigens on human monocytes identified by monoclonal antibodies. J. Immunol. 126: 1435.
Meuer, S.C., R.E. Hussey, M. Fabbi, D. Fox, O. Acuto, K.A. Fitzgerald, J.C. Hodgdon, J.P. Protentis, S.F. Schlossman, and E.L. Reinherz. 1984. An alternate pathway of T cell activation: A functional role for the 550Kd Til sheep erythrocyte receptor protein. Cell 36: 897.
Abramson, C.S., J.H. Kersey, and T.W. LeBien. 1981. A monoclonal anti-body (BA-1) reactive with cells of human B lymphocyte lineage. J. Immunol. 126: 83.
Omary, M.B., I.S. Trowbridge, and H.A. Battifora. 1980. Human homologue of murine T200 glycoprotein. J. Exp. Med. 152: 842.
Nadler, L.M., P. Stashenko, R. Hardy, J.M. Pesando, E.J. Yunis, and S.F. Schlossman. 1981. Monoclonal antibodies defining serologically distinct HLA-D/DR related la-like antigen in man. Hum. Immunol. 1: 77.
Nadler, L.M., P. Stashenko, R. Hardy, A. van Agthoven, C. Terhorst, and S.F. Schlossman. 1981. Characterization of a human B cell-specific antigen (B2) distinct from Bl. J. Immunol. 125: 1941.
Bhan, A.K., L.M. Nadler, P. Stashenko, and S.F. Schlossman. 1981. Stages of B cell differentiation in human lymphoid tissues. J. Exp. Med. 154: 737.
Hsu, S., and E.S. Jaffe. 1984. Phenotypic expression of B lymphocytes. 1. Identification with monoclonal antibodies in normal lymphoid tissues. Am. J. Pathol. 114: 387.
Anderson, K.C., M.P. Bates, B.L. Slaughenhoupt, G.S. Pinkus, S.F. Schlossman, and L.M. Nadler. 1984. Expression of human B cell-associated antigens on leukemias and lymphomas: A model of human B cell differentiation. Blood 63: 1424.
Iida, K., L.M. Nadler, and V. Nussenzweig. 1983. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J. Exp. Med. 158: 1021.
Fingeroth, J.D., J.J. Weis, T.F. Tedder, J.L. Strominger, P.A. Biro, and D.T. Fearon. 1984. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. U.S.A. 81: 4510.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag New York Inc.
About this paper
Cite this paper
Freedman, A.S., Boyd, A.W., Fisher, D.C., Schlossman, S.F., Nadler, L.M. (1986). Changes with in vitro Activation of the B Cell Panel Antigens. In: Reinherz, E.L., Haynes, B.F., Nadler, L.M., Bernstien, I.D. (eds) Leukocyte Typing II. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4848-4_37
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4848-4_37
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-9328-6
Online ISBN: 978-1-4612-4848-4
eBook Packages: Springer Book Archive